GlobeStar Therapeutics Net Income

GlobeStar Therapeutics (GSTC) currently reports a net income of $-890K as of June 2024. That compares with $-1.9M in the prior-year period — up 54.0% year over year. That is below the Industrials sector average of $28B. Use the charts on this page to explore GlobeStar Therapeutics's net income history and peer comparisons.

GlobeStar Therapeutics's net income increased from $-1.9M to $-890K — a 54.0% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlobeStar Therapeutics's net income of $-890K is lower than the Industrials sector average of $28B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

GlobeStar Therapeutics reported $-890K in net income as of June 2024. That compares with $-1.9M in the prior-year period — up 54.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-890K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is $28B. From there, open related valuation or income-statement pages for GlobeStar Therapeutics, and consider following GSTC for alerts when major investors trade the stock.